Guardant Health Inc. Common Stock vs Vanguard International High Dividend Yield ETF — how do they compare? Guardant Health Inc. Common Stock trades at $167.76 (market cap $22.22B), while Vanguard International High Dividend Yield ETF trades at $100.57 (market cap $22.80B). The key difference: Guardant Health Inc. Common Stock and Vanguard International High Dividend Yield ETF are close in size by market cap, and Guardant Health Inc. Common Stock is trading nearer its 52-week high, Vanguard International High Dividend Yield ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Guardant Health Inc. Common Stock for 1 Days and Vanguard International High Dividend Yield ETF for 50 Days on average.
| GH | VYMI | |
|---|---|---|
Market Cap | $22.22B | $22.80B |
Volume | 1,589,453 | 748,441 |
Sector | Health | Broad Market / Factor |
52-Week High | $187.22 | $107.13 |
52-Week Low | $61.73 | $82.92 |
Typical Hold Time | 1 Days | 50 Days |
Enterprise Value | $22.86B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VYMI trades at $100.53 with a slight 0.3% daily gain, though technical indicators signal bearish momentum with moving averages showing 11 sell signals versus 2 buy signals. The ETF's recent performance includes a 29% one-year return and 14.13% five-year average annual return, with strong institutional interest as firms like Envestnet increased holdings by 22% in Q2 2026. A dividend of $0.82 is scheduled for payment on September 22, 2026.
The outlook for VYMI is mixed; bullish sentiment from Seeking Alpha highlights sector catalysts in financials, energy, and healthcare supporting dividend growth, while technical bearishness and Fed rate hike impacts pose risks. Investors may find value in its 3.61% dividend yield and global diversification, but should monitor financials exposure (43.6% of holdings) amid rising rates.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Guardant Health develops blood tests for cancer care. Its tests support genomic profiling, cancer screening, recurrence monitoring, and treatment decisions.
Read more on GH →VYMI is an index-based ETF that provides exposure to non-U.S. companies across developed and emerging markets that are characterized by high dividend yields. It tracks the FTSE All-World ex US High Dividend Yield Index, offering a diversified, low-cost way to capture international income while serving as a tactical hedge against U.S. market concentration.
Read more on VYMI →